Edward Stewart Haight, MD | |
128 Neuroscience Ct, Gray, LA 70359-5209 | |
(985) 917-3007 | |
(985) 447-4209 |
Full Name | Edward Stewart Haight |
---|---|
Gender | Male |
Speciality | Neurology |
Experience | 28 Years |
Location | 128 Neuroscience Ct, Gray, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1972509818 | NPI | - | NPPES |
1484382 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084N0400X | Psychiatry & Neurology - Neurology | MD.023100 (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Our Lady Of Lourdes Regional Medical Center, Inc | Lafayette, LA | Hospital |
Terrebonne General Medical Center | Houma, LA | Hospital |
Thibodaux Regional Medical Center | Thibodaux, LA | Hospital |
Avala | Covington, LA | Hospital |
Our Lady Of The Lake Regional Medical Center | Baton rouge, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Neuro Diagnostic Monitoring, Llc | 5698939841 | 3 |
Southeast Neuroscience Center, Llc | 9032010558 | 7 |
News Archive
EffRx Pharmaceuticals SA today announced that the U.S. Food and Drug Administration (FDA) has approved BINOSTO (alendronate sodium) Effervescent Tablets, previously known as EX101, for the treatment of osteoporosis in postmenopausal women, and as a treatment to increase bone mass in men with osteoporosis. EffRx anticipates that BINOSTO will be commercially available in the United States in the third quarter of 2012.
Scientists from the Department of Cell Biology of the University of Malaga and the Andalusian Centre for Nanomedicine and Biotechnology have made progress in finding new rapid implementation therapies to combat the COVID-19 pandemic, identifying a new drug that could prevent or mitigate the consequences derived from SARS-CoV-2 infection.
Hepatologists - physicians who specialize in liver disease - say they experience workplace discrimination, especially if they are women or BIPOC (an acronym that stands for Black, Indigenous or People of Color).
Centric Research Institute today launched CIRCUMserum, the first personal care product formulated specifically for use by circumcised men. CIRCUMserum is a daily moisturizing cream made from a patent-pending blend of essential botanical oils designed to condition areas of the penis dulled by the constant exposure resulting from circumcision.
› Verified 5 days ago
Entity Name | Southeast Neuroscience Center, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1285630129 PECOS PAC ID: 9032010558 Enrollment ID: O20040505000063 |
News Archive
EffRx Pharmaceuticals SA today announced that the U.S. Food and Drug Administration (FDA) has approved BINOSTO (alendronate sodium) Effervescent Tablets, previously known as EX101, for the treatment of osteoporosis in postmenopausal women, and as a treatment to increase bone mass in men with osteoporosis. EffRx anticipates that BINOSTO will be commercially available in the United States in the third quarter of 2012.
Scientists from the Department of Cell Biology of the University of Malaga and the Andalusian Centre for Nanomedicine and Biotechnology have made progress in finding new rapid implementation therapies to combat the COVID-19 pandemic, identifying a new drug that could prevent or mitigate the consequences derived from SARS-CoV-2 infection.
Hepatologists - physicians who specialize in liver disease - say they experience workplace discrimination, especially if they are women or BIPOC (an acronym that stands for Black, Indigenous or People of Color).
Centric Research Institute today launched CIRCUMserum, the first personal care product formulated specifically for use by circumcised men. CIRCUMserum is a daily moisturizing cream made from a patent-pending blend of essential botanical oils designed to condition areas of the penis dulled by the constant exposure resulting from circumcision.
› Verified 5 days ago
Entity Name | Neuro Diagnostic Monitoring, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598030181 PECOS PAC ID: 5698939841 Enrollment ID: O20120619000630 |
News Archive
EffRx Pharmaceuticals SA today announced that the U.S. Food and Drug Administration (FDA) has approved BINOSTO (alendronate sodium) Effervescent Tablets, previously known as EX101, for the treatment of osteoporosis in postmenopausal women, and as a treatment to increase bone mass in men with osteoporosis. EffRx anticipates that BINOSTO will be commercially available in the United States in the third quarter of 2012.
Scientists from the Department of Cell Biology of the University of Malaga and the Andalusian Centre for Nanomedicine and Biotechnology have made progress in finding new rapid implementation therapies to combat the COVID-19 pandemic, identifying a new drug that could prevent or mitigate the consequences derived from SARS-CoV-2 infection.
Hepatologists - physicians who specialize in liver disease - say they experience workplace discrimination, especially if they are women or BIPOC (an acronym that stands for Black, Indigenous or People of Color).
Centric Research Institute today launched CIRCUMserum, the first personal care product formulated specifically for use by circumcised men. CIRCUMserum is a daily moisturizing cream made from a patent-pending blend of essential botanical oils designed to condition areas of the penis dulled by the constant exposure resulting from circumcision.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Edward Stewart Haight, MD Po Box 1930, Gray, LA 70359-1930 Ph: (985) 917-3007 | Edward Stewart Haight, MD 128 Neuroscience Ct, Gray, LA 70359-5209 Ph: (985) 917-3007 |
News Archive
EffRx Pharmaceuticals SA today announced that the U.S. Food and Drug Administration (FDA) has approved BINOSTO (alendronate sodium) Effervescent Tablets, previously known as EX101, for the treatment of osteoporosis in postmenopausal women, and as a treatment to increase bone mass in men with osteoporosis. EffRx anticipates that BINOSTO will be commercially available in the United States in the third quarter of 2012.
Scientists from the Department of Cell Biology of the University of Malaga and the Andalusian Centre for Nanomedicine and Biotechnology have made progress in finding new rapid implementation therapies to combat the COVID-19 pandemic, identifying a new drug that could prevent or mitigate the consequences derived from SARS-CoV-2 infection.
Hepatologists - physicians who specialize in liver disease - say they experience workplace discrimination, especially if they are women or BIPOC (an acronym that stands for Black, Indigenous or People of Color).
Centric Research Institute today launched CIRCUMserum, the first personal care product formulated specifically for use by circumcised men. CIRCUMserum is a daily moisturizing cream made from a patent-pending blend of essential botanical oils designed to condition areas of the penis dulled by the constant exposure resulting from circumcision.
› Verified 5 days ago
Donald Severinus Gervais Jr., M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 128 Neuroscience Ct, Gray, LA 70359 Phone: 985-917-3007 Fax: 985-917-3010 |